Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

CHI Podcasts

PEGS Boston 2017 | The Promise of Neoantigens for Personalized Cancer Vaccines

25 Jan 2017

Description

Philip Arlen from Precision Biologics recently spoke with CHI. He will be speaking at PEGS in the Adoptive T Cell Therapy conference on May 3rd 2017. Precision Biologics is working with cancer vaccines to develop personalized cancer treatments that target tumors without damaging healthy human tissues. For more information, please visit http://www.PEGSummit.com/TCellTherapy/

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.